Hannah Kisla, PharmD, BCOP, provides clinical pharmacy services to adult patients at both the Brown University Health Cancer Institute and the Brown University Health Specialty Pharmacy. She serves on the oncology subcommittee of the pharmacy and therapeutics committee and is involved in the development and review of evidence-based, standardized chemotherapy order sets. She precepts both residents and students during her ambulatory hematology/oncology rotation.
Education: University of New England, School of Pharmacy
Residency: PGY-1 Pharmacy Practice Residency, Rhode Island Hospital; PGY-2 Oncology Pharmacy Residency, Rhode Island Hospital
Professional/Research Interests: Malignant hematology (acute leukemias and lymphomas), bone marrow transplant, cellular therapies, and bispecific t-cell engager therapies optimization
Pronouns: She/her
Select Publications:
Nguyen NN, Huynh JP, Wu JJ, Kisla HM, Read JN, La AG, Tat D, Brown BR. Identifying health disparities in lenalidomide access. J Oncol Pharm Pract. 2025:10781552251348222.